Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$320M |
| 2 |
Gilead Sciences
GILD
|
+$266M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$213M |
| 4 |
TE Connectivity
TEL
|
+$179M |
| 5 |
Merck
MRK
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$211M |
| 2 |
CNVR
CONVERSANT INC COM STK (DE)
CNVR
|
+$117M |
| 3 |
EOG Resources
EOG
|
+$106M |
| 4 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$102M |
| 5 |
CPWR
COMPUWARE CORP
CPWR
|
+$99.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.47% |
| 2 | Technology | 14.75% |
| 3 | Financials | 11.98% |
| 4 | Industrials | 9.42% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWI
1501
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $1.13M | ﹤0.01% |
22,700
+9,780
| +76% | +$466K |
|
|
AIV
1502
Aimco
AIV
$375M
| $1.13M | ﹤0.01% |
228,207
-39,035
| -15% | -$186K |
|
|
CPL
1503
DELISTED
CPFL Energia S.A.
CPL
| $1.13M | ﹤0.01% |
87,782
| – | – |
|
1504
Telus
TU
$15.4B
| $1.13M | ﹤0.01% |
+62,200
| New | +$1.12M |
|
|
USG
1505
DELISTED
Usg
USG
| $1.13M | ﹤0.01% |
40,209
-100
| -0.2% | -$2.74K |
|
|
DHC
1506
Diversified Healthcare Trust
DHC
$1.95B
| $1.12M | ﹤0.01% |
51,156
-61,427
| -55% | -$1.35M |
|
1507
AMERISAFE
AMSF
$487M
| $1.12M | ﹤0.01% |
26,415
+6,800
| +35% | +$282K |
|
1508
MSCI
MSCI
$41.1B
| $1.12M | ﹤0.01% |
23,543
-27,157
| -54% | -$1.27M |
|
1509
Popular Inc
BPOP
$10.8B
| $1.11M | ﹤0.01% |
32,663
-6,749
| -17% | -$212K |
|
1510
Harley-Davidson
HOG
$2.88B
| $1.11M | ﹤0.01% |
16,853
-64,767
| -79% | -$4.18M |
|
|
BLT
1511
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $1.11M | ﹤0.01% |
63,197
+35,297
| +127% | +$565K |
|
|
SPLK
1512
DELISTED
Splunk Inc
SPLK
| $1.1M | ﹤0.01% |
18,712
-50,556
| -73% | -$3.1M |
|
1513
Rithm Capital
RITM
$5.7B
| $1.09M | ﹤0.01% |
+85,250
| New | +$1.08M |
|
1514
Strategy Inc
MSTR
$50.4B
| $1.09M | ﹤0.01% |
67,000
-77,160
| -54% | -$1.22M |
|
|
NIO
1515
DELISTED
NUVEEN MUNICIPAL OPPORTUNITY FUND INC
NIO
| $1.09M | ﹤0.01% |
74,041
-46,861
| -39% | -$677K |
|
|
RWT
1516
Redwood Trust
RWT
$592M
| $1.08M | ﹤0.01% |
55,000
-6,724
| -11% | -$126K |
|
|
PXD
1517
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.08M | ﹤0.01% |
7,263
-30,741
| -81% | -$5.07M |
|
1518
LKQ Corp
LKQ
$6.47B
| $1.08M | ﹤0.01% |
38,395
-37,420
| -49% | -$1.04M |
|
1519
BlackRock MuniYield Michigan Quality Fund
MIY
$365M
| $1.08M | ﹤0.01% |
77,787
+7,967
| +11% | +$109K |
|
1520
Sally Beauty Holdings
SBH
$1.53B
| $1.08M | ﹤0.01% |
35,047
+11,900
| +51% | +$354K |
|
|
PPO
1521
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $1.08M | ﹤0.01% |
22,900
+12,700
| +125% | +$576K |
|
|
ICPT
1522
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.08M | ﹤0.01% |
6,900
-17,700
| -72% | -$3.27M |
|
|
HBANP
1523
DELISTED
Huntington Bancshars Inc. Pfd Ser A
HBANP
| $1.07M | ﹤0.01% |
800
| – | – |
|
1524
Acadia Pharmaceuticals
ACAD
$5.22B
| $1.07M | ﹤0.01% |
33,774
-3,600
| -10% | -$102K |
|
1525
Nuveen Quality Municipal Income Fund
NAD
$2.73B
| $1.07M | ﹤0.01% |
74,678
-20,932
| -22% | -$296K |
|
Similar funds
Cliff Asness's Q4 2014 Portfolio in Review
As of Q4 2014, Cliff Asness held 2,816 positions worth $47.8B, up 31% from $36.4B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Cliff Asness deployed $7.61B of net new capital in Q4 2014, opening 319 new positions and adding to 937 existing holdings. Its largest new stake was LyondellBasell Industries: 3,695,296 shares worth $293M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was EOG Resources, an estimated $106M trimmed.
- Cliff Asness's largest Q4 2014 buy was LyondellBasell Industries: 3,695,296 shares worth $293M.
- Cliff Asness added most to Gilead Sciences in Q4 2014, an estimated $266M increase.
- Cliff Asness's biggest Q4 2014 reduction was EOG Resources, cutting an estimated $106M.
- Cliff Asness fully exited Shire pic in Q4 2014, selling an estimated $211M.
- Cliff Asness's ten largest holdings make up 9.3% of its $47.8B portfolio in Q4 2014.
- Cliff Asness opened 319 new positions and closed 310 in Q4 2014.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $47.8B.
Based on AQR Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.